TriSalus Life Sciences Inc. (TLSI) — Cash Flow-to-Debt Ratio
TriSalus Life Sciences Inc. (TLSI) has a Cash Flow-to-Debt Ratio of -0.30x as of June 2026, meaning its operating cash flow of $-16.61 Million could theoretically repay 0% of its total liabilities ($55.90 Million) in one year. See financial flexibility index of TriSalus Life Sciences Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TriSalus Life Sciences Inc. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for TriSalus Life Sciences Inc. across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does TriSalus Life Sciences Inc. generate cash.
Annual Cash Flow-to-Debt Ratio for TriSalus Life Sciences Inc. (2021–2025)
Year-by-year debt coverage analysis for TriSalus Life Sciences Inc.. Check TriSalus Life Sciences Inc. (TLSI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-18.01 Million | $69.19 Million | ▲ +68.2% |
| 2024 | -0.82x | $-40.84 Million | $49.87 Million | ▲ +16.3% |
| 2023 | -0.98x | $-50.58 Million | $51.66 Million | ▼ -4.0% |
| 2022 | -0.94x | $-32.31 Million | $34.32 Million | ▲ +71.2% |
| 2021 | -3.27x | $-22.70 Million | $6.93 Million | — |